SciELO - Scientific Electronic Library Online

 
vol.22 issue1Pulmonary - renal syndrome: case series Hospital Universitario San IgnacioThe role of ultrasound in the subclinical assessment of rheumatoid arthritis in remission. Systematic review of the literature author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Revista Colombiana de Reumatología

Print version ISSN 0121-8123

Abstract

DIAZ-CORTES, Diana et al. Central nervous system involvement in systemic lupus erythematosus. Rev.Colomb.Reumatol. [online]. 2015, vol.22, n.1, pp.16-30. ISSN 0121-8123.  https://doi.org/10.1016/j.rcreu.2015.02.001.

Objectives: To review the epidemiological, pathophysiological, and neurological manifestations, as well as the diagnosis and treatment of central nervous system involvement in systemic lupus erythematosus. Methods: A literature search was performed using PubMed database complemented by review of literature references listed in identified articles. There were no limits to publication date of the literature references. Only articles in English and Spanish were included. Results: Central nervous system involvement is one of the major causes of morbidity and mortality in systemic lupus erythematosus patients. Common disorders (cumulative incidence >5%) were cerebrovascular disease and seizures, and relatively uncommon (1-5%) were severe cognitive dysfunction, acute confusional state, psychosis, while the remaining neuropsychiatric disorders were unusual (less than 1%). Mechanisms that can lead to neuropsychiatric manifestations include intracranial vascular lesions (vasculitis and thrombosis), autoantibody production against neuronal antigens, ribosomes, and phospholipids, and inflammation related to local cytokine production. Serological tests, cerebrospinal fluid, and imaging investigations have been used to support the clinical diagnosis. Treatment is based on the use of corticosteroids, immunosuppressants, and symptomatic treatment. The use of antiplatelet and antithrombotic drugs was indicated when positive moderate-to-high titres of anti-phospholipid antibodies were present. Conclusions: The involvement of vital organs and tissues, such as the brain, in patients with systemic lupus erythematosus, impels efforts to develop diagnostic tools for systemic lupus erythematosus associated neuropsychiatric disease to guide effective therapeutic decisions. © 2014 Asociación Colombiana de Reumatología. Published by Elsevier España, S.L.U

Keywords : Systemic lupus erythematosus Vasculitis; Seizures; Morbidity; Mortality.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )